Clinical Trial Update: First In Human Randomised Trial of Rincell-1 in Adults With a Cochlear Implant [Phase 1, Phase 2]

View source ↗

Summary

This update reports a first-in-human, randomized Phase 1/2 trial of Rincell-1 for adults with cochlear implants. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Auditory Neuropathy
• Presbycusis
• Sensorineural Hearing Loss

Drugs mentioned

• Rincell-1

Snippet

Sponsor: Rinri Therapeutics | Conditions: Sensorineural Hearing Loss, Presbyacusis | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING